A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan J Lewis, MD, PhD
ZIOPHARM Oncology, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Milan, Italy
- Facility name not stated
Padova, Italy
- Facility name not stated
Torino, Italy
- Facility name not stated
Cluj-Napoca, Romania
- Facility name not stated
Lasi, Romania
- Facility name not stated
Santa Monica, California, United States
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Coeur d'Alene, Idaho, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Park Ridge, Illinois, United States
- Facility name not stated
Iowa City, Iowa, United States
- Facility name not stated
Lenaxa, Kansas, United States
- Facility name not stated
Albuquerque, New Mexico, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Durham, North Carolina, United States
- Facility name not stated
Portland, Oregon, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Memphis, Tennessee, United States
- Facility name not stated
Nashville, Tennessee, United States
- Facility name not stated
San Antonio, Texas, United States
- Facility name not stated
Salt Lake City, Utah, United States
- Facility name not stated
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 30 Apr 2012
- Completion
- 30 Apr 2014
- Last update posted
- 30 Jan 2014
- Registered enrollment
- 67
- Registry id
- NCT00718484
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.